These findings suggest that LRP11 promotes HCC growth, metastasis, and lipid synthesis in vivo, suggesting that LRP11 may serve as a potential therapeutic target for limiting tumor progression and metastasis in HCC. Here, LRP11 is linked to hepatocellular carcinoma.